Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Nevertheless, the association was not distinctly altered by chronic kidney disease.Subgroup analyses for the association between anemia and quartiles of S-Klotho (pg/mL) among the study participants, weightedanemiaS-Klotho Quartile, OR (95% CI)P-interactionQuartile 1 (496.7, 613.9)Quartile 2 (690.9, 763.4)Quartile 3 (840.8, 935.5)Quartile 4 (1060.8, 1330.9)Age\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{a}$$\end{document}a0.561 40-591.38(1.00, 1.91)1.17 (0.86, 1.60)1.00 (0.73, 1.35)Reference 60-791.85 (1.31,2.62)1.57 (1.11, 2.21)1.12 (0.78, 1.62)ReferenceGender\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{b}$$\end{document}b0.005 Male2.81 (1.89,4.19)1.79 (1.25, 2.58)1.39 (0.96, 2.03)Reference Female1.15 (0.85,1.54)1.17 (0.85, 1.59)0.93 (0.69, 1.26)ReferenceBody mass index\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{c}$$\end{document}c0.418 < 25.0 kg/m\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{2}$$\end{document}21.53 (0.99,2.34)1.53 (0.94, 2.49)0.87 (0.56, 1.36)Reference 25.0-29.9 kg/m\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{2}$$\end{document}21.43 (0.88,2.33)0.87 (0.53, 1.43)0.91 (0.58, 1.43)Reference \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge$$\end{document}≥ 30.0 kg/m\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{2}$$\end{document}21.66 (1.15, 2.40)1.51 (1.09, 2.11)1.25 (0.86, 1.83)ReferenceDiabetes\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{d}$$\end{document}d0.005 no1.25 (0.97, 1.60)1.11 (0.82, 1.51)0.93 (0.71, 1.22)Reference yes2.70 (1.80, 4.05)2.06 (1.32, 3.21)1.42 (0.91, 2.20)ReferenceChronic kidney disease\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{e}$$\end{document}e0.186 no1.40 (1.05, 1.87)1.37 (1.05, 1.79)1.00 (0.73, 1.36)Reference yes1.90 (1.26, 2.89)1.11 (0.72, 1.72)1.14 (0.75, 1.75)Referencea: Modified for gender, race, marital status (having a partner, others), poverty-to-income ratio (<1.3,1.3-2.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$>=$$\end{document}>=3.0), education level (< high school, high school, > high school), alcohol intake (no, yes), smoke (never, former, now), moderate-vigorous physical activity, body mass index (<25.0, 25.0-29.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge$$\end{document}≥30.0), high waist circumference, phosphorus, calcium, serum iron, albumin, uric acid, urinary albumin/creatinine ratio, estimated glomerular filtration rate, serum 25-hydroxyvitamin D, DFE deficiency, Vitamin B12 deficiency, Iron intake deficiency, angina, heart attack, coronary heart disease, congestive heart failure, stroke, hypertension, hyperlipidemia, diabetes, chronic kidney diseases, cancer, and rheumatoid arthritis.b: Modified for age, race, marital status (having a partner, others), poverty-to-income ratio(<1.3,1.3-2.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$>=$$\end{document}>=3.0), education level (< high school, high school, > high school), alcohol intake (no, yes), smoke (never, former, now), moderate-vigorous physical activity, body mass index (<25.0, 25.0-29.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge$$\end{document}≥30.0), high waist circumference, phosphorus, calcium, serum iron, albumin, uric acid, urinary albumin/creatinine ratio, estimated glomerular filtration rate, serum 25-hydroxyvitamin D, DFE deficiency, Vitamin B12 deficiency, Iron intake deficiency, angina, heart attack, coronary heart disease, congestive heart failure, stroke, hypertension, hyperlipidemia, diabetes, chronic kidney diseases, cancer, and rheumatoid arthritis.c: Modified for age, gender, race, marital status (having a partner, others), poverty-to-income ratio(<1.3,1.3-2.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$>=$$\end{document}>=3.0), education level (< high school, high school, > high school), alcohol intake (no, yes), smoke (never, former, now), moderate-vigorous physical activity, high waist circumference, phosphorus, calcium, serum iron, albumin, uric acid, urinary albumin/creatinine ratio, estimated glomerular filtration rate, serum 25-hydroxyvitamin D, DFE deficiency, Vitamin B12 deficiency, Iron intake deficiency, angina, heart attack, coronary heart disease, congestive heart failure, stroke, hypertension, hyperlipidemia, diabetes, chronic kidney diseases, cancer, and rheumatoid arthritis.d: Modified for age, gender, race, marital status (having a partner, others), poverty-to-income ratio(<1.3,1.3-2.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$>=$$\end{document}>=3.0), education level (< high school, high school, > high school), alcohol intake (no, yes), smoke (never, former, now), moderate-vigorous physical activity, body mass index (<25.0, 25.0-29.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge$$\end{document}≥30.0), high waist circumference, phosphorus, calcium, serum iron, albumin, uric acid, urinary albumin/creatinine ratio, estimated glomerular filtration rate, serum 25-hydroxyvitamin D, DFE deficiency, Vitamin B12 deficiency, Iron intake deficiency, angina, heart attack, coronary heart disease, congestive heart failure, stroke, hypertension, hyperlipidemia, chronic kidney diseases, cancer, and rheumatoid arthritis.e: Modified for age, gender, race, marital status (having a partner, others), poverty-to-income ratio(<1.3,1.3-2.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$>=$$\end{document}>=3.0), education level (< high school, high school, > high school), alcohol intake (no, yes), smoke (never, former, now), moderate-vigorous physical activity, body mass index (<25.0, 25.0-29.9, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\ge$$\end{document}≥30.0), high waist circumference, phosphorus, calcium, serum iron, albumin, uric acid, urinary albumin/creatinine ratio, estimated glomerular filtration rate, serum 25-hydroxyvitamin D, DFE deficiency, Vitamin B12 deficiency, Iron intake deficiency, angina, heart attack, coronary heart disease, congestive heart failure, stroke, hypertension, hyperlipidemia, diabetes, cancer, and rheumatoid arthritis.Abbreviations: OR odd ratio, CI confidence interval

Source: Stratified analyses by age, gender, BMI, diabetes, and chronic kidney disease. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this cross-sectional study, we used data collected from the National Health and Nutrition Examination Survey (NHANES) 2007-2016.

Source: Abstract.

Pregnant women were excluded (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$n = 5$$\end{document}n=5).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between anemia and serum Klotho in middle-aged and older adults

Cross-sectional study · BMC Nephrology · 2023

Original publication title

Association between anemia and serum Klotho in middle-aged and older adults

Chencheng An; Xiaoling Chen; Donghui Zheng

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In summary, we indicated that low serum Klotho is associated with an increased likelihood of anemia using a nationally representative sample of middle-aged and older adults.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The role of Klotho as a multifunctional protein in anemia is unclear. This study aimed to determine the association between anemia and serum Klotho concentrations in middle-aged and elderly populations.

Source: Background

Abstract: What methods does the paper describe?

In this cross-sectional study, we used data collected from the National Health and Nutrition Examination Survey (NHANES) 2007-2016. A total of 13,357 individuals who received serum Klotho measurements, biochemical tests, and demographic surveys were analyzed. Multivariate linear regression models adjusting for covariates were used to investigate the associations between anemia and serum Klotho.

Source: Methods

Abstract: Results

Multivariable regression showed that serum Klotho correlates positively with hemoglobin and red blood cells and inversely with red cell distribution width. After adjusting for all covariates, compared with Q4, there was a significantly increased risk of anemia in serum Klotho quartiles 1 to 2 (OR=1.54, 95% CI:1.21-1.95, P=0.002; OR=1.30, 95% CI:1.02-1.64, P=0.042,respectively). Segmented regression showed that for every 100 pg/mL increase in serum Klotho <9.746 pg/mL, the risk of anemia was reduced by 10.9%, and this reduction was significant (P<0.001).

Furthermore, stratified analyses yielded a stronger association between reduced anemia and high levels of Klotho in men and those with diabetes (P< 0.05 for interaction). However, this association was not found to be significantly altered by chronic kidney disease.

Source: Results

Abstract: Conclusions

In summary, we indicated that low serum Klotho is associated with an increased likelihood of anemia using a nationally representative sample of middle-aged and older adults.

Source: Conclusions
Authors’ abstract

Background

The role of Klotho as a multifunctional protein in anemia is unclear. This study aimed to determine the association between anemia and serum Klotho concentrations in middle-aged and elderly populations.

Methods

In this cross-sectional study, we used data collected from the National Health and Nutrition Examination Survey (NHANES) 2007-2016. A total of 13,357 individuals who received serum Klotho measurements, biochemical tests, and demographic surveys were analyzed. Multivariate linear regression models adjusting for covariates were used to investigate the associations between anemia and serum Klotho.

Results

Multivariable regression showed that serum Klotho correlates positively with hemoglobin and red blood cells and inversely with red cell distribution width. After adjusting for all covariates, compared with Q4, there was a significantly increased risk of anemia in serum Klotho quartiles 1 to 2 (OR=1.54, 95% CI:1.21-1.95, P=0.002; OR=1.30, 95% CI:1.02-1.64, P=0.042,respectively). Segmented regression showed that for every 100 pg/mL increase in serum Klotho <9.746 pg/mL, the risk of anemia was reduced by 10.9%, and this reduction was significant (P<0.001).

Furthermore, stratified analyses yielded a stronger association between reduced anemia and high levels of Klotho in men and those with diabetes (P< 0.05 for interaction). However, this association was not found to be significantly altered by chronic kidney disease.

Conclusions

In summary, we indicated that low serum Klotho is associated with an increased likelihood of anemia using a nationally representative sample of middle-aged and older adults.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12882-023-03081-w.

Publication and source details

Original title: Association between anemia and serum Klotho in middle-aged and older adults

Chencheng An; Xiaoling Chen; Donghui Zheng

BMC Nephrology · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:32:45.512617+00:00

DOI: 10.1186/s12882-023-03081-w · PMC9933285